Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 433

1.

Detection of the BLV provirus from nasal secretion and saliva samples using BLV-CoCoMo-qPCR-2: Comparison with blood samples from the same cattle.

Yuan Y, Kitamura-Muramatsu Y, Saito S, Ishizaki H, Nakano M, Haga S, Matoba K, Ohno A, Murakami H, Takeshima SN, Aida Y.

Virus Res. 2015 Aug 19. pii: S0168-1702(15)30045-9. doi: 10.1016/j.virusres.2015.08.013. [Epub ahead of print]

PMID:
26298004
2.

Clinical and Counseling Experiences of Early Adopters of Whole Exome Sequencing.

Arora S, Haverfield E, Richard G, Haga SB, Mills R.

J Genet Couns. 2015 Aug 19. [Epub ahead of print]

PMID:
26283062
3.

Seasonal foraging patterns of forest-grazing Japanese Black heifers with increased plasma total antioxidant capacity.

Haga S, Nakano M, Nakao S, Hirano K, Yamamoto Y, Sasaki H, Ishizaki H.

Anim Sci J. 2015 Aug 13. doi: 10.1111/asj.12408. [Epub ahead of print]

PMID:
26270936
4.

Mitochondrial delivery of Coenzyme Q10via systemic administration using a MITO-Porter prevents ischemia/reperfusion injury in the mouse liver.

Yamada Y, Nakamura K, Abe J, Hyodo M, Haga S, Ozaki M, Harashima H.

J Control Release. 2015 Jul 6;213:86-95. doi: 10.1016/j.jconrel.2015.06.037. [Epub ahead of print]

PMID:
26160304
5.

Patient beliefs and behaviors about genomic risk for type 2 diabetes: implications for prevention.

Gallagher P, King HA, Haga SB, Orlando LA, Joy SV, Trujillo GM, Scott WM, Bembe M, Creighton DL, Cho AH, Ginsburg GS, Vorderstrasse A.

J Health Commun. 2015;20(6):728-35. doi: 10.1080/10810730.2015.1018563. Epub 2015 Apr 6.

PMID:
25844569
6.

Potential use of auxiliary labels to promote patient awareness of pharmacogenetic testing.

Haga SB, Moaddeb J.

Pharmacogenomics. 2015;16(4):299-301. doi: 10.2217/pgs.14.184. No abstract available.

7.

Challenges to integrating pharmacogenetic testing into medication therapy management.

Haga SB, Allen LaPointe NM, Moaddeb J.

J Manag Care Spec Pharm. 2015 Apr;21(4):346-52.

8.

Nurses' communication of pharmacogenetic test results as part of discharge care.

Haga SB, Mills R.

Pharmacogenomics. 2015;16(3):251-6. doi: 10.2217/pgs.14.173.

PMID:
25712188
9.

[Cerebellar abscess due to infection with the anaerobic bacteria fusobacterium nucleatum: a case report].

Shimogawa T, Sayama T, Haga S, Akiyama T, Morioka T.

No Shinkei Geka. 2015 Feb;43(2):137-42. doi: 10.11477/mf.1436202969. Japanese.

PMID:
25672555
10.

Genetically guided statin therapy on statin perceptions, adherence, and cholesterol lowering: a pilot implementation study in primary care patients.

Li JH, Joy SV, Haga SB, Orlando LA, Kraus WE, Ginsburg GS, Voora D.

J Pers Med. 2014 Mar 27;4(2):147-62. doi: 10.3390/jpm4020147.

11.

Pilot study: incorporation of pharmacogenetic testing in medication therapy management services.

Haga SB, Allen LaPointe NM, Moaddeb J, Mills R, Patel M, Kraus WE.

Pharmacogenomics. 2014 Nov;15(14):1729-1737.

PMID:
25493566
12.

Developing patient-friendly genetic and genomic test reports: formats to promote patient engagement and understanding.

Haga SB, Mills R, Pollak KI, Rehder C, Buchanan AH, Lipkus IM, Crow JH, Datto M.

Genome Med. 2014 Jul 31;6(7):58. doi: 10.1186/s13073-014-0058-6. eCollection 2014.

13.

Accumulation of carboxy-terminal fragments of APP increases phosphodiesterase 8B.

Kametani F, Haga S.

Neurobiol Aging. 2015 Feb;36(2):634-7. doi: 10.1016/j.neurobiolaging.2014.09.029. Epub 2014 Oct 7.

PMID:
25457556
14.

Growth arrest and DNA damage-inducible 34 regulates liver regeneration in hepatic steatosis in mice.

Inaba Y, Furutani T, Kimura K, Watanabe H, Haga S, Kido Y, Matsumoto M, Yamamoto Y, Harada K, Kaneko S, Oyadomari S, Ozaki M, Kasuga M, Inoue H.

Hepatology. 2015 Apr;61(4):1343-56. doi: 10.1002/hep.27619. Epub 2015 Feb 23.

PMID:
25420998
15.

Pilot study of pharmacist-assisted delivery of pharmacogenetic testing in a primary care setting.

Haga SB, LaPointe NM, Cho A, Reed SD, Mills R, Moaddeb J, Ginsburg GS.

Pharmacogenomics. 2014 Sep;15(13):1677-86. doi: 10.2217/pgs.14.109.

16.

Direct and indirect suppression of interleukin-6 gene expression in murine macrophages by nuclear orphan receptor REV-ERBα.

Sato S, Sakurai T, Ogasawara J, Shirato K, Ishibashi Y, Oh-ishi S, Imaizumi K, Haga S, Hitomi Y, Izawa T, Ohira Y, Ohno H, Kizaki T.

ScientificWorldJournal. 2014;2014:685854. doi: 10.1155/2014/685854. Epub 2014 Oct 14.

17.

Usefulness of continuous suture using short-thread double-armed micro-suture for cerebral vascular anastomosis.

Haga S, Nagata S.

Surg Neurol Int. 2014 Oct 21;5:153. doi: 10.4103/2152-7806.143366. eCollection 2014.

18.

Pharmacogenetic information for patients on drug labels.

Haga SB, Mills R, Moaddeb J.

Pharmgenomics Pers Med. 2014 Oct 3;7:297-305. doi: 10.2147/PGPM.S67876. eCollection 2014.

19.

Overview of software options for processing, analysis and interpretation of mass spectrometric proteomic data.

Haga SW, Wu HF.

J Mass Spectrom. 2014 Oct;49(10):959-69. doi: 10.1002/jms.3414. Review.

PMID:
25303385
20.

A novel ACE2 activator reduces monocrotaline-induced pulmonary hypertension by suppressing the JAK/STAT and TGF-β cascades with restored caveolin-1 expression.

Haga S, Tsuchiya H, Hirai T, Hamano T, Mimori A, Ishizaka Y.

Exp Lung Res. 2015 Feb;41(1):21-31. doi: 10.3109/01902148.2014.959141. Epub 2014 Oct 2.

PMID:
25275723
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk